Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record history adds a new revision entry labeled v3.5.4 and removes the previous v3.5.3, indicating an updated revision of the study record.
    Difference
    0.1%
    Check dated 2026-05-20T15:37:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 has been added to the record history and the previous v3.5.2 entry has been removed, reflecting an updated revision of the study record.
    Difference
    0.1%
    Check dated 2026-04-29T09:17:17.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s footer revision identifier changes from v3.5.0 to v3.5.2 without affecting any study record fields shown on the record history page.
    Difference
    0.1%
    Check dated 2026-04-22T05:34:30.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the Record History page.
    Difference
    0.1%
    Check dated 2026-03-24T10:58:20.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision entry v3.4.3 was added to the study record history, and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-10T02:48:31.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The record history now includes a new revision v3.4.2 and removes v3.4.1 from the history. This update affects only the history log and not the study data.
    Difference
    0.1%
    Check dated 2026-02-16T15:33:23.000Z thumbnail image

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.